Multiple variants in GLP1R have been found to affect how well the receptor responds which is why clinical trials of GLP-1 drugs show some patients lose dramatically more weight than others on the exact same medication
The pathways that regulate weight are incredibly complicated, said Dr
Our findings in the ZSF1 obese rat model provide novel mechanistic insight that aligns with these clinical data
This is concerning because different "normal" but suboptimal micronutrient levels (also called marginal deficiencies or inadequacies) have been associated with various chronic health conditions, including cardiovascular disease, cancers, and stroke
This material is intended only for institutional investors and may not be distributed to retail investors
Metabolic and nutrient-related signalling cascades that have been linked to NLRP3 inflammasome activity, such as ketone metabolism and gut dysbiosis, might be potential therapeutic avenues for the treatment of AF 298,299